Infección por Covid-19 en pacientes de 18 a 90 años de edad con enfermedades reumatológicas y/o autoinmunes en el Hospital General del Norte de Guayaquil Los Ceibos durante el periodo de marzo del 2020 a mayo del 2022.

Abstract

Background: The COVID-19 pandemic has had significant impacts, therefore, given the great uncertainty regarding COVID-19 infection in patients with rheumatic diseases, a deep interest was expressed in the field of immunology to know the role of immunity in infection, in addition to clarifying with scientific evidence what are the outcomes of rheumatological patients. Objective: To analyze the evolution of the COVID-19 infection in patients diagnosed with rheumatic and/or autoimmune diseases. Materials and methods: Observational, retrospective study in patients diagnosed with inflammatory rheumatic disease, diagnosed by rheumatologists, and infected with the SARS-CoV-2 virus treated at the General Hospital of the North IESS Los Ceibos. Results: The study included 40 patients, 34 (85%) were women, with a total mean age of 53.90 ± 13.85 years. The mean duration of symptoms in patients with symptomatic infection was 9 days. The most frequent rheumatic diseases were Rheumatoid Arthritis (12; 30%) and Psoriatic Arthritis (12; 30%), covering the same number of patients. It showed a significant correlation for CKD hospitalization (p=0.002); SLE (p=0.002) and age >50. Conclusion: Patients > 50 years old, those with systemic lupus erythematosus, and patients with chronic kidney disease, showed a higher risk for hospitalization.